Biomedical Engineering and Emergency Medicine, University of Virginia Health System, Charlottesville, VA, USA.
J Environ Pathol Toxicol Oncol. 2010;29(4):363-72. doi: 10.1615/jenvironpatholtoxicoloncol.v29.i4.70.
This scientific article was designed to teach the individual reader the scientific basis for suture and needle selection as well as to illustrate the appropriate surgical techniques involved in wound repair of skin incisions. Because the US Food and Drug Administration permits 1.5% of the sterile surgical gloves to have holes, the operating room personnel should wear sterile surgical double-glove hole indication systems that detect holes in the outer glove. From the surgeon's point of view, the rate of gain of strength of the skin wound is a key determinant of many decisions including when the suture can be removed, the level of patient activity, and the selection of the incision. Important considerations in wound closure are type of suture and mechanical performance, in vivo and in vitro. Measurements of the in vivo degradation of sutures separate them into two general classes, absorbable and nonabsorbable. Sutures that undergo rapid degradation in tissues, losing their tensile strength within 60 days, are considered absorbable. Those that maintain their tensile strength for longer than 60 days are considered nonabsorbable. For skin closure with nonabsorbable suture, we favor the use of the polybutester suture that is coated with an absorbable polymer, VASCUFIL™. When absorbable sutures are used for a dermal skin closure, the synthetic monofilament MAXON™ is recommended. Absorption of the suture is complete between 90 and 110 days. In either case, we would recommend that the suture be attached by a sewage attachment to a SURGALLOY™ reverse cutting stainless steel suture. Continuous percutaneous suture closure has definite, distinct advantages over interrupted suture closure. Although continuous dermal wound closure is technically more challenging for the surgeon than interrupted dermal suture closure, it has become an important wound closure technique. A monofilament absorbable synthetic MAXON™ attached to a reverse cutting edge SURGALLOY™ stainless steel needle is ideally suited for continuous dermal skin suture closure.
这篇科学文章旨在向个体读者传授缝线和针选择的科学基础,并说明皮肤切口伤口修复所涉及的适当手术技术。由于美国食品和药物管理局允许 1.5%的无菌手术手套有孔,手术室人员应佩戴无菌手术双层手套孔指示系统,以检测外手套上的孔。从外科医生的角度来看,皮肤伤口的强度增加率是许多决策的关键决定因素,包括何时可以拆除缝线、患者活动水平以及切口选择。伤口闭合的重要考虑因素包括缝线类型和机械性能,包括体内和体外。体内缝线降解的测量将缝线分为两类,可吸收缝线和不可吸收缝线。在组织中迅速降解、在 60 天内失去拉伸强度的缝线被认为是可吸收的。那些在 60 天以上保持其拉伸强度的缝线被认为是不可吸收的。对于不可吸收缝线的皮肤闭合,我们倾向于使用涂有可吸收聚合物的聚丁酯缝线 VASCUFIL™。当可吸收缝线用于真皮皮肤闭合时,推荐使用合成单丝 MAXON™。缝线的吸收在 90 至 110 天之间完全吸收。在这两种情况下,我们都建议将缝线通过污水附件连接到 SURGALLOY™反向切割不锈钢缝线。连续经皮缝线闭合与间断缝线闭合相比具有明确的优势。虽然连续真皮伤口闭合对外科医生来说在技术上比间断真皮缝线闭合更具挑战性,但它已成为一种重要的伤口闭合技术。单丝可吸收合成 MAXON™连接到反向切割边缘 SURGALLOY™不锈钢针非常适合连续真皮皮肤缝线闭合。